Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New aqueous inflow inhibitors.

J W Doyle1, M F Smith

  • 1Department of Ophthalmology, University of Florida, Gainesville, FL 32610, USA.

Seminars in Ophthalmology
|May 3, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Modeling the movement of Oecophylla smaragdina on short-length scales in an unfamiliar environment.

Movement ecology·2024
Same author

Modeling the movement of Oecophylla smargandina on short-length scales in an unfamiliar environment.

Movement ecology·2023
Same author

Influence of preovulatory estradiol treatment on the maintenance of pregnancy in beef cattle receiving in vivo produced embryos.

Animal reproduction science·2023
Same author

Effect of estradiol preceding and progesterone subsequent to ovulation on proportion of postpartum beef cows pregnant.

Animal reproduction science·2021
Same author

What best animal science teachers do.

Translational animal science·2021
Same author

Resistive switching in diamondoid thin films.

Scientific reports·2020

New glaucoma medications, including alpha agonists and carbonic anhydrase inhibitors, effectively reduce aqueous humor production. These agents show comparable efficacy to timolol, offering various benefits and drawbacks for patients.

Area of Science:

  • Ophthalmology
  • Pharmacology

Background:

  • Elevated intraocular pressure (IOP) is a primary risk factor for glaucoma.
  • Aqueous humor dynamics play a crucial role in IOP regulation.
  • Timolol has been a standard treatment for IOP reduction.

Purpose of the Study:

  • To review and compare newly available aqueous humor inflow inhibitors.
  • To evaluate the efficacy of novel glaucoma pharmacotherapies against timolol.

Main Methods:

  • Review of recently introduced ophthalmic medications.
  • Categorization of agents: alpha agonists, topical carbonic anhydrase inhibitors, and combination therapies.
  • Comparative analysis of aqueous suppression with timolol.

Main Results:

Related Experiment Videos

  • Several new agents demonstrate favorable aqueous suppression compared to timolol.
  • New classes include alpha agonists, topical carbonic anhydrase inhibitors, and a novel combination agent.
  • Each new agent possesses distinct advantages and disadvantages.

Conclusions:

  • Newer pharmacologic options offer effective alternatives for reducing aqueous humor production.
  • Clinicians can select agents based on individual patient profiles and specific treatment goals.
  • These advancements expand therapeutic options for managing glaucoma.